About this trial
In this pilot observational study the primary outcome is to assess, in a Respiratory Rehabilitation Unit, if there is an association between sarcopenia, assessed by handgrip strenght and BIA, and a delayed decannulation time in patients who underwent tracheostomy.
Secondary outcomes are to assess if there is an association between an increased malnutrition risk (assessed by MUST), a poor nutritional status (assessed by GLIM criteria) and a delayed decannulation time and the gut microbiota composition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signed informed consent from patients or legal guardians for patients unfit to plead
Presence of tracheostomy at admission
Disqualifiers
Refusal
Pregnancy
Pace maker/implantable cardioverter
No legal guardians for patients unfit to plead
Trial population
Patients who underwent tracheostomy before admission, attending a rehabilitation program
Trial design
Cohort
Prospective
Treatments tested in this trial
handgrip strenght
Diagnostic testMuscle strenght measured with a handheld dynamometer, at admission (T0) and at decannulation time (T1)
Bioelectrical Impedance Analysis (BIA)
Diagnostic testMuscle mass evaluated by Bioelectrical Impedance Analysis (BIA), at admission (T0) and at decannulation time (T1)
MUST
Diagnostic testMalnutrition risk assessed by Malnutrition Universal Screening Tool (MUST), at admission (T0) and at decannulation time (T1)
GLIM
Diagnostic testMalnutrition diagnosis performed by Global Leadership Initiative on Malnutrition (GLIM) criteria, at admission (T0) and at decannulation time (T1)
Gut microbiota
Biological/VaccineA fecal sample obtained at admission (T0) and at decannulation time (T1)
Blood Sample
Biological/VaccineA Blood sample obtained at admission (T0) and at decannulation time (T1)
Anthropometric measures
Other interventionMeasurement of weight and height (assessed only at admission) to calculate the Body Mass Index (BMI), at admission (T0) and at decannulation time (T1)
Treatment groups
Trial outcomes
Primary outcomes
Change from admission in muscle mass at decannulation time
Measurement of muscle mass with Bioelectrical Impedance Analysis (BIA).
Change from admission in hangrip strenght at decannulation time
Measurement of handgrip strenght with a handheld dynamometer. Male cut-off: \<27 Kg Female cut-off: \<16 Kg
Secondary outcomes
Change from admission in Body Mass Index (BMI) score at decannulation time
Measurement of height and weight to get a BMI score (weight/(height\^2). BMI \<18.5 Kg/m\^2: underweight BMI 18.5-24.9 Kg/m\^2: normal range BMI 25.0-29.9 Kg/m\^2: overweight BMI 30.0-34.9 Kg/m\^2 obese class I BMI 35.0-39.9 Kg/m\^2 obese class II BMI \>= 40 Kg/m\^2 obese class III
Change from admission in Malnutrition Universal Screening Tool (MUST) score at decannulation time
MUST is a screening tool to identify adults who are malnourished, at risk of malnutrition or obese. score 0: low risk score 1: medium risk score 2 or more: high risk
Change from admission in nutritional status at decannulation time
Global Leadership Initiative on Malnutrition (GLIM) criteria are 5 diagnostic criteria to assess malnutrition that include 3 phenotypic (weight loss, low body mass index and reduced muscle mass) and 2 etiologic (reduced food intake/assimilation, and inflammation/disease burden) criteria. To diagnose malnutrition at least 1 phenotypic criterion and 1 etiologic criterion should be present.
Change from admission in Gut Microbiota (GM) composition at decannulation time
Gut Microbiota (GM) composition
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondazione Don Carlo Gnocchi Onlus
Lead sponsor
University of Florence
Collaborator